Arthritis drug sells despite concerns
507003
BEIJING, Dec. 23 -- Celebrex, a painkiller prescribed to people with arthritis, is still selling well in Shanghai even though US experts recently found an increased risk of heart attacks and strokes for patients taking high dosages of the drug.
19693
An arthritis drug should have been taken off the market years before it was finally withdrawn, say researchers. Manufacturer Merck withdrew Vioxx in September after evidence linking it to heart problems.
326965
AUSTRALIAâS drug regulator is fast-tracking a review into a class of arthritis drugs which are believed to increase the risk of heart attack.
196262
Some analysts are betting Pfizer Inc.  won't have to withdraw its arthritis drug Celebrex but they do  expect sales to fall after a study of the drug in cancer  patients showed it increased the risk of heart attacks.
684774
Pfizer Inc.'s pain  reliever Celebrex should be approved for treating rheumatoid  arthritis in children despite uncertainty about the risks of  long-term use, U.S. advisers said on Wednesday.
144122
Scientists uncover why some arthritis drugs such as Vioxx can cause heart attacks and strokes.
569487
Bulging costs keep the drugmaker from showing a profit.
109705
Tampa, Florida - If you or someone you know is taking the arthritis drug, Vioxx, itâs been pulled from the market. The manufacturer, Merck &amp; Co.
277613
[India News]: New York, Dec 20 : America&#39;s multibillion dollar pharmaceutical industry has been shaken by reports that Pfizer&#39;s high-profile arthritis drug, Celebrex, is said to cause an increased risk of heart attack.
163791
The arthritis drug Vioxx, used by 2  million people around the world, is being pulled off the market  after a study confirmed longstanding concerns that it raises  the risk of heart attack and stroke, the manufacturer, Merck &  Co. MRK.N, said on Thursday.
557373
Cambridge Antibody Technology Group Plc  has won a UK court case to get a bigger slice of sales of a  potential blockbuster arthritis medicine, sending its shares  more than 25 percent higher on Monday.
253460
An arthritis drug should have been taken off the market years before it was finally withdrawn, say researchers.
286317
As drugmakers scramble to grab Vioxx&#39;s multi-billion-dollar share of the arthritis and pain-relief market, patients might find themselves wondering whether the competing medications are much safer.
45984
Drug company Pfizer said today it is continuing to promote its arthritis drug Celebrex to doctors despite reports it more than doubles the risk of heart attacks and strokes.
538035
Users of an anti-arthritis drug linked by a study to an increased risk of heart attacks and strokes have been urged not to panic. The UK Department of Health said users of Celebrex, manufactured by US drug
398323
Still reeling from Merck&#39;s withdrawal of Vioxx from the market and Pfizer&#39;s decision to stop advertising Celebrex, people who suffer from arthritis pain now have one more worry: The US Food and Drug Administration announced Monday that it was halting a
90441
The drug maker says a three-year study of the arthritis pain medication demonstrated a higher risk of heart attack and stroke in patients using the drug.